SCHEMBL3662847

SCHEMBL3662847

CCC=CCCCOc1cccc(NC)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.38
TDP1 Q9NUW8 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP2D6 P10635 1/20 0.34
KMT2A Q03164 1/20 0.33
SLC6A4 P31645 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HRH1 P35367 1/20 0.33
PPARG P37231 1/20 0.32
PTPN1 P18031 1/20 0.32
CACNA1B Q00975 1/20 0.32
APP P05067 1/20 0.32
HTR1B P28222 2/20 0.31
EPHX2 P34913 2/20 0.31
NR1I2 O75469 1/20 0.31
PGR P06401 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
PTGS2 P35354 1/20 0.31
PDE4D Q08499 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3771932 1.00 L3MBTL1 (0.38) L3MBTL1TDP1CYP1A2CYP2C19CYP2D6
SCHEMBL3770873 0.96 L3MBTL1 (0.37) L3MBTL1TDP1KMT2ASLC6A4HRH1
SCHEMBL3661806 0.96 L3MBTL1 (0.37) L3MBTL1TDP1KMT2ASLC6A4HRH1
SCHEMBL3772711 0.93 EDNRA (0.33) L3MBTL1TDP1CYP1A2CYP2C19CYP2D6
SCHEMBL3662881 0.93 EDNRA (0.33) L3MBTL1TDP1CYP1A2CYP2C19CYP2D6
SCHEMBL3662544 0.92 L3MBTL1 (0.38) L3MBTL1TDP1CYP1A2CYP2C19CYP2D6
SCHEMBL3766391 0.92 L3MBTL1 (0.38) L3MBTL1TDP1CYP1A2CYP2C19CYP2D6
SCHEMBL3764580 0.88 PTPN1 (0.38) L3MBTL1CYP1A2CYP2C19KMT2AALDH1A1
SCHEMBL3660872 0.88 PTPN1 (0.38) L3MBTL1CYP1A2CYP2C19KMT2AALDH1A1
SCHEMBL3770862 0.87 L3MBTL1 (0.36) L3MBTL1TDP1CYP1A2CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 L3MBTL1 40/4885TDP1 4310/4885CYP1A2 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.